| Literature DB >> 34950120 |
Xiaoqi Zang1, Hongyue Lv1, Haiyan Tang2, Xinan Jiao3, Jinlin Huang1,2,3.
Abstract
Campylobacter jejuni (C. jejuni) is the leading causative agent of gastroenteritis and Guillain-Barré syndrome (GBS). Capsular polysaccharide (CPS) and lipooligosaccharide (LOS) contribute to the susceptibility of campylobacteriosis, which have been concern the major evaluation indicators of C. jejuni isolates from clinical patients. As a foodborne disease, food animal plays a primary role in the infection of campylobacteriosis. To assess the pathogenic characterizations of C. jejuni isolates from various ecological origins, 1609 isolates sampled from 2005 to 2019 in China were analyzed using capsular genotyping. Strains from cattle and poultry were further characterized by LOS classification and multilocus sequence typing (MLST), compared with the isolates from human patients worldwide with enteritis and GBS. Results showed that the disease associated capsular genotypes and LOS classes over-represented in human isolates were also dominant in animal isolates, especially cattle isolates. Based on the same disease associated capsular genotype, more LOS class types were represented by food animal isolates than human disease isolates. Importantly, high-risk lineages CC-22, CC-464, and CC-21 were found dominated in human isolates with GBS worldwide, which were also represented in the food animal isolates with disease associated capsular types, suggesting a possibility of clonal spread of isolates across different regions and hosts. This is the first study providing genetic evidence for food animal isolates of particular capsular genotypes harbor similar pathogenic characteristics to human clinical isolates. Collective efforts for campylobacteriosis hazard control need to be focused on the zoonotic pathogenicity of animal isolates, along the food chain "from farm to table."Entities:
Keywords: Campylobacter jejuni; capsular genotype; enteritis and Guillain–Barré syndrome; isolates from food animal; lipooligosaccharide class; multilocus sequence typing
Year: 2021 PMID: 34950120 PMCID: PMC8690235 DOI: 10.3389/fmicb.2021.775090
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Comparison of capsular genotype with proportional estimates by Campylobacter jejuni isolates source and collection year.
| Capsular genotype | Source of | Collection year | Total ( | ||||||
| Poultry ( | Enteritis patient ( | Cattle ( | Pet ( | Monkey ( | 2005–2008 ( | 2014–2016 ( | 2017–2019 ( | ||
| HS2 | 10.42% (113/1084) | 13.08% (31/237) | 25.97% (47/181) | 12.73% (7/55) | 13.46% (7/52) | 10.07% (58/576) | 16.67% (23/138) | 13.85% (124/895) | 12.74% (205/1609) |
| HS4A c | 13.10% (142/1084) | 11.81% (28/237) | 11.05% (20/181) | 5.45% (3/55) | 5.77% (3/52) | 15.45% (89/576) | 0.00% (0/138) | 11.96% (107/895) | 12.18% (196/1609) |
| HS1 | 7.84% (85/1084) | 12.66% (30/237) | 3.31% (6/181) | 12.73% (7/55) | 1.92% (1/52) | 10.76% (62/576) | 16.67% (23/138) | 4.92% (44/895) | 8.02% (129/1609) |
| HS8/17 | 6.64% (72/1084) | 7.17% (17/237) | 8.29% (15/181) | 0.00% (0/55) | 7.69% (4/52) | 6.60% (38/576) | 18.84% (26/138) | 4.92% (44/895) | 6.71% (108/1609) |
| HS6 | 4.43% (48/1084) | 2.53% (6/237) | 1.10% (2/181) | 0.00% (0/55) | 5.77% (3/52) | 1.39% (8/576) | 5.80% (8/138) | 4.80% (43/895) | 3.67% (59/1609) |
| HS53 | 3.87% (42/1084) | 2.11% (5/237) | 3.87% (7/181) | 1.82% (1/55) | 0.00% (0/52) | 5.73% (33/576) | 2.17% (3/138) | 2.12% (19/895) | 3.42% (55/1609) |
| HS37 | 3.32% (36/1084) | 4.64% (11/237) | 3.31% (6/181) | 0.00% (0/55) | 1.92% (1/52) | 3.82% (22/576) | 2.17% (3/138) | 3.24% (29/895) | 3.36% (54/1609) |
| HS4B c | 1.66% (18/1084) | 2.53% (6/237) | 9.94% (18/181) | 0.00% (0/55) | 5.77% (3/52) | 3.30% (19/576) | 0.00% (0/138) | 2.91% (26/895) | 2.80% (45/1609) |
| HS23/36 | 1.38% (15/1084) | 6.33% (15/237) | 1.66% (3/181) | 5.45% (3/55) | 3.85% (2/52) | 3.65% (21/576) | 2.90% (4/138) | 1.45% (13/895) | 2.36% (38/1609) |
| HS3 | 1.57% (17/1084) | 7.17% (17/237) | 1.10% (2/181) | 7.27% (4/55) | 1.92% (1/52) | 4.34% (25/576) | 2.90% (4/138) | 1.34% (12/895) | 2.55% (41/1609) |
| HS10 | 2.12% (23/1084) | 2.11% (5/237) | 2.21% (4/181) | 0.00% (0/55) | 0.00% (0/52) | 2.43% (14/576) | 2.90% (4/138) | 1.56% (14/895) | 1.99% (32/1609) |
| HS19 | 0.46% (5/1084) | 2.95% (7/237) | 9.94% (18/181) | 3.64% (2/55) | 0.00% (0/52) | 2.78% (16/576) | 2.17% (3/138) | 1.45% (13/895) | 1.99% (32/1609) |
| HS9 | 1.85% (20/1084) | 1.69% (4/237) | 0.55% (1/181) | 7.27% (4/55) | 0.00% (0/52) | 2.95% (17/576) | 2.17% (3/138) | 1.01% (9/895) | 1.80% (29/1609) |
| HS21 | 1.94% (21/1084) | 3.80% (9/237) | 0.00% (0/181) | 1.82% (1/55) | 1.92% (1/52) | 1.74% (10/576) | 10.14 (14/138) | 0.89% (8/895) | 1.99% (32/1609) |
| HS5/31 | 1.29% (14/1084) | 3.38% (8/237) | 1.66% (3/181) | 1.82% (1/55) | 5.77% (3/52) | 1.39% (8/576) | 2.90% (4/138) | 2.01% (18/895) | 1.80% (29/1609) |
| HS44 | 0.92% (10/1084) | 0.42% (1/237) | 0.55% (1/181) | 3.64% (2/55) | 1.92% (1/52) | 0.69% (4/576) | 1.45% (2/138) | 1.01% (9/895) | 0.93% (15/1609) |
| HS42 | 0.37% (4/1084) | 2.95% (7/237) | 0.00% (0/181) | 0.00% (0/55) | 0.00% (0/52) | 1.56% (9/576) | 0.00% (0/138) | 0.22% (2/895) | 0.68% (11/1609) |
| HS12 | 0.00% (0/1084) | 1.69% (4/237) | 0.55% (1/181) | 0.00% (0/55) | 0.00% (0/52) | 0.69% (4/576) | 0.00% (0/138) | 0.11% (1/895) | 0.31% (5/1609) |
| HS41 | 0.00% (0/1084) | 0.00% (0/237) | 0.00% (0/181) | 0.00% (0/55) | 5.77% (3/52) | 0.00% (0/576) | 0.00% (0/138) | 0.34% (3/895) | 0.19% (3/1609) |
| HS15/31 | 0.00% (0/1084) | 0.42% (1/237) | 0.55% (1/181) | 0.00% (0/55) | 0.00% (0/52) | 0.17% (1/576) | 0.00% (0/138) | 0.11% (1/895) | 0.12% (2/1609) |
FIGURE 1Proportional representation of capsular genotypes among Campylobacter jejuni isolates. (A) Frequency of capsular genotype among isolates from different year intervals. Colors of the lines indicate isolates from different year intervals. (B) Frequency of capsular genotype among isolates from enteritis patient, monkey, pet, cattle, and poultry. Colors of the bars indicate isolates from different sources.
FIGURE 2Proportional representations of the disease related capsular genotypes and lipooligosaccharide classes among Campylobacter jejuni isolates from different sources. (A) GBS associated capsular genotype. (B) Enteritis associated capsular genotype. (C) Lipooligosaccharide classes. (D) Heat map demonstrates the correlation between lipooligosaccharide class and disease associated capsular genotype.
FIGURE 3Genetic diversity of Campylobacter jejuni isolates from animals and patients. (A) The minimum spanning tree shows population structure of C. jejuni isolates. Circles correspond to different sequence types. The size of circle proportional to the number of isolates with a certain sequence type. Colors of the circles indicate isolates from different sources. (B) A tree constructed by Neighbor Joinning algorithm. Saitou–Nei criterion was selected for tree branch-length minimization.
FIGURE 4Comparison of sequence types among Campylobacter jejuni isolates from different sources. These isolates include 37 animal isolates with disease associated serotypes, 28 enteritis isolates, and 32 GBS isolates from PubMLST. (A) Venn diagram shows the sequence types of isolates from GBS patients, enteritis patients, and animals. (B) Venn diagram shows the sequence types of isolates from GBS patients, enteritis patients, poultry, and cattle.